The report is concentrated on the implementation of China New Medical Reform Policy and its influence on China medicine industry. The report analyzes the forthcoming National Essential Medicine List 2012 and conducts a statistics work on provinces added list. Besides, it also had a specific analysis on marketing channel of China medicine enterprises under New Medical Reform Policy. Generally, the report can provide advantageous reference for insiders and help you understand comprehensively China's current health reform process.

Table Of Contents

1. China New Medical Reform Policy Specific Analysis
1.1 Medical Reform History
1.1.1 Reasons of the Past Fail Cases
1.1.2 Basic Medical and Health System Mode of New Medical Reform Policy
1.1.3 Phasic Results of Three-year of Medical and Health Reform
1.2 Primary Care and Public Health Solve “Treatment Difficulty”
1.2.1 Reasons of “Treatment Difficulty”
1.2.2 Measures to Solve “Treatment Difficulty”
1.3 Medical Insurance, Basic Medicines, and Public Hospitals Reform Solve “Treatment Expensiveness”
1.3.1 Reasons of “Treatment Expensiveness”
1.3.2 Measures to Solve “Treatment Expensiveness”
1.4 New Medical Reform Policy Influence on Medical Enterprises
1.4.1 Opportunities and Challenges Brought by Medical Reform to Medical Enterprises
1.4.2 Influence of Medical Reform on Foreign Investment and Joint Ventures’ Market Share
1.4.3 Organization of Medical and Health Reform in 2012
1.4.4 New Medical Reform Policy Shows Clearly the Future Direction of the Medical Reform
1.5 Influence of Medical Reform on Foreign Owned, Joint Ventures and China State-owned Enterprises
1.5.1 Influence on Foreign Owned Enterprises
1.5.2 Influence on Joint Ventures
1.5.3 Influence on China State-owned Enterprises
1.6 Strategy Analysis of Joint Ventures Coping with New Medical Reform Policy
1.6.1 Attach Importance to the Research and Development of Chinese Medicine and Patent Medicines
1.6.2 Pay Attention to the Medicine Needs of the Rural and Community
1.6.3 Adjust Strategy to Adapt to the Flat Channel
1.7 Industrial Pattern of Medicine Enterprises
1.7.1 Current Industrial Merger and Acquisition
1.7.2 Industry Concentration Ratio Planning during the “Twelfth Five-Year” Period
1.8 Forecast and Influence of Drug Code Adjustment in the Future
1.8.1 Comprehensive Check of the Drug Approval Number after the Implementation of New Medical Reform Policy
1.8.2 Drug Registration Approval Data Interpretation, 2008-2011
1.8.3 The “Twelfth Five-Year” Plan Required to Further Give Full Play to the Role of Drug Regulation

2. Medicine Marketing Channel Change under New Medical Reform
2.1 Marketing Channel of Medicine Enterprise
2.1.1 Main Marketing Channel of Different Medicine Categories
2.1.2 Original Marketing Channel
2.1.3 Development Trend of Marketing Channel
2.2 Influence of New Medical Reform Policy on Medicine Marketing
2.2.1 Expansion of Market Capacity and Surge of Generic Medicine Market
2.2.2 Change of Terminal Market and Rise of the Third Terminal
2.2.3 Much More Professional Marketing Mode
2.3 Influence of New Medical Reform Policy on Medicine Enterprises’ Marketing Channel
2.3.1 Influence on Foreign Owned Enterprises
2.3.2 Influence on Joint Ventures
2.2.3 Influence on China Domestic Enterprises
2.4 Joint Ventures’ Marketing Strategy under New Medical Reform
2.4.1 In Accordance With Polarization of Medicine Market
2.4.2 Enhance Marketing Activity with the Help of Commercial Channels
2.4.3 Improve the Quality of Employees via Professional Training
2.4.4 Organic Combination of Academic and public welfare

3. The Latest National Essential Medicine List and the Provinces Added List
3.1 Interpretation of New Version of the National Essential Medicine List
3.1.1 The Leadership of the Ministry of Health’s Interpretation of New Version of the National Essential Medicine List
3.1.2 Interpretation of Informal Version of National Essential Medicine List
3.2 Provinces Added List

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • August 2014
  • by Global Data

PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023 Summary Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  • $ 10 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely ...

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • Dec 2014
  • by BCC Research

REPORT HIGHLIGHTS The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach $4.3 billion in 2019, registering a compound ...


2 Companies

Company Profiles

Medicines Co.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.